• Ali A M AlHabobi, Ashwaq M S Almutairi, Danah A S Y Bohemid, and Ashwini R Sehgal.
• Division of Nephrology, McMaster University, Hamilton, Ontario, Canada (A.A.M.A., A.M.S.A., D.A.S.Y.B.).
• Ann. Intern. Med. 2024 May 1; 177 (5_Supplement): S47S56S47-S56.

AbstractThis article highlights a selection of important nephrology studies published in 2023 that have relevance for nonnephrologist physicians. Four studies examined progression of chronic kidney disease or cardiovascular disease with respect to finerenone use, magnesium supplementation, iron markers, and COVID-19. Two studies examined treatments to improve specific aspects of chronic kidney disease management, including daprodustat to address anemia and patiromer to address hyperphosphatemia. One study showed that acetazolamide added to loop diuretics increased diuresis in acute decompensated heart failure across a wide range of renal function. Another study found that once-daily hydrochlorothiazide did not prevent kidney stone recurrence. Finally, an antibiotic stewardship intervention safely reduced antibiotic prescribing for suspected urinary tract infection in frail older adults.

25 keywords...

hide…